Effects of tranexamic acid treatment in severely and non-severely injured trauma patients.
Transfusion · 2022-06-24 · Meta-analysis
Abstract
BACKGROUND: Urgent treatment with tranexamic acid (TXA) reduces bleeding deaths but there is disagreement about which patients should be treated. We examine the effects of TXA treatment in severely and non-severely injured trauma patients. STUDY DESIGN AND METHODS: We did an individual patient data meta-analysis of randomized trials with over 1000 trauma patients that assessed the effects of TXA on survival. We defined the severity of injury according to characteristics at first assessment: systolic blood pressure of less than 90 mm Hg and a heart rate greater than 120 beats per minute or Glasgow Coma Scale score of less than nine or any GCS with one or more fixed dilated pupils. The primary measure was survival on the day of the injury. We examined the effect of TXA on survival in severely and non-severely injured patients and how these effects vary with the time from injury to treatment. RESULTS: We obtained data for 32,944 patients from two randomized trials. Tranexamic acid significantly increased survival on the day of the injury (OR = 1.22, 95% CI 1.11-1.34; p < .01). The effect of tranexamic acid on survival in non-severely injured patients (OR = 1.25, 1.03-1.50) was similar to that in severely injured patients (OR = 1.22, 1.09-1.37) with no significant heterogeneity (p = .87). In severely and non-severely injured pateints, treatment within the first hour after injury was the most effective. DISCUSSION: Early tranexamic acid treatment improves survival in both severely and non-severely injured trauma patients. Its use should not be restricted to the severely injured.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Haemostatics · Time intervals · Tranexamic acid · Mortality & survival
Related articles
- Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (Lancet, 2018)
- Tranexamic Acid Timing and Mortality Impact After Trauma. (Ann Emerg Med, 2026)
- Time to early resuscitative intervention association with mortality in trauma patients at risk for hemorrhage. (J Trauma Acute Care Surg, 2023)
- Early Prehospital Tranexamic Acid Following Injury Is Associated With a 30-day Survival Benefit: A Secondary Analysis of a Randomized Clinical Trial. (Ann Surg, 2021)
- Evaluation of new quality indicators for the TraumaRegister DGU® using the systematic QUALIFY methodology. (Eur J Trauma Emerg Surg, 2020)
- The effects of timing of prehospital tranexamic acid on outcomes after traumatic brain injury: Subanalysis of a randomized controlled trial. (J Trauma Acute Care Surg, 2023)